Leanne de Koning Selected Research

Leanne de Koning Research Topics

Disease

16	Neoplasms (Cancer) 10/2023 - 03/2012
7	Breast Neoplasms (Breast Cancer) 12/2020 - 03/2015
5	Uveal melanoma 10/2023 - 05/2019
3	Neoplasm Metastasis (Metastasis) 10/2023 - 01/2016
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 08/2017
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2020 - 12/2016
2	Colorectal Neoplasms (Colorectal Cancer) 08/2018 - 12/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 12/2023
1	Squamous Cell Carcinoma of Head and Neck 12/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Alcoholic Fatty Liver 01/2021
1	Triple Negative Breast Neoplasms 01/2020
1	Carcinogenesis 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Glioma (Gliomas) 01/2019
1	Hypersensitivity (Allergy) 01/2019
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 07/2018
1	Liver Neoplasms (Liver Cancer) 08/2017
1	Carcinoma (Carcinomatosis) 03/2016
1	Homocystinuria 06/2013
1	Hyperhomocysteinemia 06/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2013

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2012
7	Biomarkers (Surrogate Marker)IBA 12/2023 - 03/2015
5	Messenger RNA (mRNA)IBA 01/2020 - 06/2013
2	Phenobarbital (Luminal)FDA Link 01/2020 - 03/2015
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 12/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 08/2017 - 01/2016
1	AfatinibIBA 12/2023
1	Macrophage Colony-Stimulating FactorIBA 01/2023
1	NivolumabIBA 01/2022
1	IpilimumabIBA 01/2022
1	talazoparibIBA 01/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	hepatitis B virus X proteinIBA 01/2021
1	veliparibIBA 01/2021
1	CateninsIBA 01/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021
1	AntigensIBA 12/2020
1	AntibodiesIBA 12/2020
1	PhosphoproteinsIBA 11/2020
1	Genetic Markers (Genetic Marker)IBA 11/2020
1	beta CateninIBA 11/2020
1	Forkhead Box Protein O1IBA 01/2020
1	enzalutamideIBA 01/2020
1	sotrastaurinIBA 01/2020
1	Forkhead Box Protein O3IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Protein Kinase CIBA 01/2020
1	Androgen Receptors (Androgen Receptor)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2019
1	cabozantinibIBA 01/2019
1	Sorafenib (BAY 43-9006)FDA Link 01/2019
1	Gefitinib (Iressa)FDA Link 01/2019
1	MTOR InhibitorsIBA 07/2018
1	olaparibIBA 07/2018
1	Everolimus FDA Link 07/2018
1	ARQ 197IBA 08/2017
1	5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA 08/2017
1	JNJ38877605IBA 08/2017
1	Vinblastine (Vinblastine Sulfate)FDA Link 08/2017
1	Actin-Related Protein 2-3 Complex (Arp2 3 Complex)IBA 03/2016
1	taxaneIBA 01/2016
1	Lim KinasesIBA 01/2016
1	ChromatinIBA 03/2015
1	Histone ChaperonesIBA 03/2015
1	Cystathionine beta-Synthase (Serine Sulfhydrase)IBA 06/2013
1	Vitamin B Complex (B Vitamins)IBA 06/2013
1	HomocysteineIBA 06/2013
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 06/2013
1	Histones (Histone)IBA 03/2012

Therapy/Procedure

6	Therapeutics 10/2023 - 03/2015
2	Radiotherapy 01/2021 - 01/2019
1	Drug Therapy (Chemotherapy) 05/2019
1	Precision Medicine 12/2016